Cellceutix Corporation announced the informed shareholders that its Chief Medical Officer, Dr. Daniel Jorgensen, will be leaving the company, effective March 31, 2016, in order to pursue a unique opportunity in his specialized field at a privately held company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | +14.29% | -61.90% | -83.67% |
Feb. 01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-83.67% | 423K | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- IPIX Stock
- News Innovation Pharmaceuticals Inc.
- Daniel Jorgensen Leaves Cellceutix Corporation as Chief Medical Officer, Effective March 31, 2016